Home The Word Brain	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Ear2Memory – Free App | Free PDF | Web Learning languages on your smartphone By BSK	Free Abstracts

Colorectal Neoplasms

Free Subscription Articles published in PLoS One Retrieve available abstracts of 168 articles: HTML format Text format

Single Articles

January 2017
1. ZHANG S, Deng Z, Yao C, Huang P, et al
   AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms.
   PLoS One. 2017;12:e0169585.
   PubMed     Text format     Abstract available
   
   
   
2. HUANG WS, Kuo YH, Kuo HC, Hsieh MC, et al
   CIL-102-Induced Cell Cycle Arrest and Apoptosis in Colorectal Cancer Cells via Upregulation of p21 and GADD45.
   PLoS One. 2017;12:e0168989.
   PubMed     Text format     Abstract available
   
   
   
3. LU M, Zessin AS, Glover W, Hsu DS, et al
   Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis.
   PLoS One. 2017;12:e0169439.
   PubMed     Text format     Abstract available
   
   
   
4. WU R, Feng J, Yang Y, Dai C, et al
   Significance of Serum Total Oxidant/Antioxidant Status in Patients with Colorectal Cancer.
   PLoS One. 2017;12:e0170003.
   PubMed     Text format     Abstract available
   
   
   
5. LI Y, Wang WY, Xiao JH, Xu F, et al
   Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients.
   PLoS One. 2017;12:e0167868.
   PubMed     Text format     Abstract available
   
   
   
6. FROUWS MA, Reimers MS, Swets M, Bastiaannet E, et al
   The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis.
   PLoS One. 2017;12:e0170775.
   PubMed     Text format     Abstract available
   
   
   
7. QIN M, Zhang J, Xu C, Peng P, et al
   Knockdown of NIK and IKKbeta-Binding Protein (NIBP) Reduces Colorectal Cancer Metastasis through Down-Regulation of the Canonical NF-kappaBeta Signaling Pathway and Suppression of MAPK Signaling Mediated through ERK and JNK.
   PLoS One. 2017;12:e0170595.
   PubMed     Text format     Abstract available
   
   
   
8. SOO HC, Chung FF, Lim KH, Yap VA, et al
   Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT Pathway.
   PLoS One. 2017;12:e0170551.
   PubMed     Text format     Abstract available
   
   
   
9. KINAR Y, Akiva P, Choman E, Kariv R, et al
   Performance analysis of a machine learning flagging system used to identify a group of individuals at a high risk for colorectal cancer.
   PLoS One. 2017;12:e0171759.
   PubMed     Text format     Abstract available
   
   
   
10. PENG Y, Yang H, Ye Q, Zhou H, et al
    Inhibition of peritoneal dissemination of colon cancer by hyperthermic CO2 insufflation: A novel approach to prevent intraperitoneal tumor spread.
    PLoS One. 2017;12:e0172097.
    PubMed     Text format     Abstract available
    
    
    
11. ZHAI H, Shi Y, Chen X, Wang J, et al
    CacyBP/SIP promotes the proliferation of colon cancer cells.
    PLoS One. 2017;12:e0169959.
    PubMed     Text format     Abstract available
    
    
    
12. FAN G, Zhang K, Yang X, Ding J, et al
    Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.
    PLoS One. 2017;12:e0171991.
    PubMed     Text format     Abstract available
    
    
    
13. ALI H, Bitar MS, Al Madhoun A, Marafie M, et al
    Functionally-focused algorithmic analysis of high resolution microarray-CGH genomic landscapes demonstrates comparable genomic copy number aberrations in MSI and MSS sporadic colorectal cancer.
    PLoS One. 2017;12:e0171690.
    PubMed     Text format     Abstract available
    
    
    
14. ZERIOUH W, Nani A, Belarbi M, Dumont A, et al
    Phenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway.
    PLoS One. 2017;12:e0170823.
    PubMed     Text format     Abstract available
    
    
    
15. LI P, Xiao Z, Braciak TA, Ou Q, et al
    A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
    PLoS One. 2017;12:e0172799.
    PubMed     Text format     Abstract available
    
    
    
16. PRIETO I, Del Puerto-Nevado L, Gonzalez N, Portal-Nunez S, et al
    Colon cancer modulation by a diabetic environment: A single institutional experience.
    PLoS One. 2017;12:e0172300.
    PubMed     Text format     Abstract available
    
    
    
17. KATHER JN, Zollner FG, Schad LR, Melchers SM, et al
    Identification of a characteristic vascular belt zone in human colorectal cancer.
    PLoS One. 2017;12:e0171378.
    PubMed     Text format     Abstract available
    
    
    
18. WEBER L, Al-Refae K, Ebbert J, Jagers P, et al
    Activation of odorant receptor in colorectal cancer cells leads to inhibition of cell proliferation and apoptosis.
    PLoS One. 2017;12:e0172491.
    PubMed     Text format     Abstract available
    
    
    
19. SARSHEKEH AM, Advani S, Overman MJ, Manyam G, et al
    Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.
    PLoS One. 2017;12:e0173345.
    PubMed     Text format     Abstract available
    
    
    
20. THEAN LF, Wong YH, Lo M, Loi C, et al
    Chromosome 19q13 disruption alters expressions of CYP2A7, MIA and MIA-RAB4B lncRNA and contributes to FAP-like phenotype in APC mutation-negative familial colorectal cancer patients.
    PLoS One. 2017;12:e0173772.
    PubMed     Text format     Abstract available
    
    
    
21. TASHIRO T, Okuyama H, Endo H, Kawada K, et al
    In vivo and ex vivo cetuximab sensitivity assay using three-dimensional primary culture system to stratify KRAS mutant colorectal cancer.
    PLoS One. 2017;12:e0174151.
    PubMed     Text format     Abstract available
    
    
    
22. GOEDE SL, Rabeneck L, van Ballegooijen M, Zauber AG, et al
    Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.
    PLoS One. 2017;12:e0172864.
    PubMed     Text format     Abstract available
    
    
    
23. CARLSON GE, Martin EW, Shirure VS, Malgor R, et al
    Dynamic biochemical tissue analysis detects functional L-selectin ligands on colon cancer tissues.
    PLoS One. 2017;12:e0173747.
    PubMed     Text format     Abstract available
    
    
    
24. SHINKINS B, Nicholson BD, Primrose J, Perera R, et al
    The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial.
    PLoS One. 2017;12:e0171810.
    PubMed     Text format     Abstract available
    
    
    
25. SIMICZYJEW A, Mazur AJ, Dratkiewicz E, Nowak D, et al
    Involvement of beta- and gamma-actin isoforms in actin cytoskeleton organization and migration abilities of bleb-forming human colon cancer cells.
    PLoS One. 2017;12:e0173709.
    PubMed     Text format     Abstract available
    
    
    
26. HUANG WY, Ho CL, Lee CC, Hsiao CW, et al
    Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer.
    PLoS One. 2017;12:e0174280.
    PubMed     Text format     Abstract available
    
    
    
27. YANG M, Xiao X, Xing X, Li X, et al
    KRAS and VEGF gene 3'-UTR single nucleotide polymorphisms predicted susceptibility in colorectal cancer.
    PLoS One. 2017;12:e0174140.
    PubMed     Text format     Abstract available
    
    
    
28. WIEGERING A, Riegel J, Wagner J, Kunzmann V, et al
    The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases.
    PLoS One. 2017;12:e0173933.
    PubMed     Text format     Abstract available
    
    
    
29. BERGER AW, Schwerdel D, Welz H, Marienfeld R, et al
    Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA.
    PLoS One. 2017;12:e0174308.
    PubMed     Text format     Abstract available
    
    
    
30. NAGAPPAN A, Lee WS, Yun JW, Lu JN, et al
    Tetraarsenic hexoxide induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt suppression and p38 MAPK activation in SW620 human colon cancer cells.
    PLoS One. 2017;12:e0174591.
    PubMed     Text format     Abstract available
    
    
    
31. ANDRES-FRANCH M, Galiana A, Sanchez-Hellin V, Ochoa E, et al
    Streptococcus gallolyticus infection in colorectal cancer and association with biological and clinical factors.
    PLoS One. 2017;12:e0174305.
    PubMed     Text format     Abstract available
    
    
    
32. NIRVANAPPA AC, Mohan CD, Rangappa S, Ananda H, et al
    Correction: Novel Synthetic Oxazines Target NF-kappaB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
    PLoS One. 2017;12:e0175659.
    PubMed     Text format     Abstract available
    
    
    
33. ZHOU Y, Zhang X, Zhang J, Fang J, et al
    LRG1 promotes proliferation and inhibits apoptosis in colorectal cancer cells via RUNX1 activation.
    PLoS One. 2017;12:e0175122.
    PubMed     Text format     Abstract available
    
    
    
34. CARVALHO AC, Leal F, Sasse AD
    Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer.
    PLoS One. 2017;12:e0175409.
    PubMed     Text format     Abstract available
    
    
    
35. BURMEISTER K, Quagliata L, Andreozzi M, Eppenberger-Castori S, et al
    Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes.
    PLoS One. 2017;12:e0175563.
    PubMed     Text format     Abstract available
    
    
    
36. CAO G, Cheng D, Ye L, Pan Y, et al
    Surgical resection of pulmonary metastases from colorectal cancer: 11 years of experiences.
    PLoS One. 2017;12:e0175284.
    PubMed     Text format     Abstract available
    
    
    
37. ZERIOUH W, Nani A, Belarbi M, Dumont A, et al
    Correction: Phenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway.
    PLoS One. 2017;12:e0176574.
    PubMed     Text format     Abstract available
    
    
    
38. ZHU B, Wu X, Wu B, Pei D, et al
    The relationship between diabetes and colorectal cancer prognosis: A meta-analysis based on the cohort studies.
    PLoS One. 2017;12:e0176068.
    PubMed     Text format     Abstract available
    
    
    
39. BAILEY KL, Agarwal E, Chowdhury S, Luo J, et al
    TGFbeta/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells.
    PLoS One. 2017;12:e0176096.
    PubMed     Text format     Abstract available
    
    
    
40. SHARMA A, Vatapalli R, Abdelfatah E, Wyatt McMahon K, et al
    Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells.
    PLoS One. 2017;12:e0176139.
    PubMed     Text format     Abstract available
    
    
    
41. KIM HJ, Jo MJ, Kim BR, Kim JL, et al
    Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients.
    PLoS One. 2017;12:e0176834.
    PubMed     Text format     Abstract available
    
    
    
42. SHIN SJ, Chun SM, Kim TI, Kim YJ, et al
    Feasibility of multiplexed gene mutation detection in plasma samples of colorectal cancer patients by mass spectrometric genotyping.
    PLoS One. 2017;12:e0176340.
    PubMed     Text format     Abstract available
    
    
    
43. PEREYRA D, Offensperger F, Klinglmueller F, Haegele S, et al
    Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity.
    PLoS One. 2017;12:e0175359.
    PubMed     Text format     Abstract available
    
    
    
44. LI Y, Li J, Liu H, Liu Y, et al
    Expression of MYSM1 is associated with tumor progression in colorectal cancer.
    PLoS One. 2017;12:e0177235.
    PubMed     Text format     Abstract available
    
    
    
45. LAKATOS E, Salehi-Reyhani A, Barclay M, Stumpf MPH, et al
    Protein degradation rate is the dominant mechanism accounting for the differences in protein abundance of basal p53 in a human breast and colorectal cancer cell line.
    PLoS One. 2017;12:e0177336.
    PubMed     Text format     Abstract available
    
    
    
46. 
    Correction: Identification of a characteristic vascular belt zone in human colorectal cancer.
    PLoS One. 2017;12:e0177586.
    PubMed     Text format     Abstract available
    
    
    
47. PRIETO V, Ludwig JM, Farris AB, Nagaraju GP, et al
    Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study.
    PLoS One. 2017;12:e0177212.
    PubMed     Text format     Abstract available
    
    
    
48. LEE JY, Lee MK, Kim NK, Chu SH, et al
    Serum chemerin levels are independently associated with quality of life in colorectal cancer survivors: A pilot study.
    PLoS One. 2017;12:e0176929.
    PubMed     Text format     Abstract available
    
    
    
49. 
    Correction: Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.
    PLoS One. 2017;12:e0178275.
    PubMed     Text format     Abstract available
    
    
    
50. GONZALEZ-DONQUILES C, Alonso-Molero J, Fernandez-Villa T, Vilorio-Marques L, et al
    The NRF2 transcription factor plays a dual role in colorectal cancer: A systematic review.
    PLoS One. 2017;12:e0177549.
    PubMed     Text format     Abstract available
    
    
    
51. PARK JY, Kim SH, Lee SM, Lee JS, et al
    CT volumetric measurement of colorectal cancer helps predict tumor staging and prognosis.
    PLoS One. 2017;12:e0178522.
    PubMed     Text format     Abstract available
    
    
    
52. LI J, Li Y, Liu H, Liu Y, et al
    The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis.
    PLoS One. 2017;12:e0178515.
    PubMed     Text format     Abstract available
    
    
    
53. OSUMI H, Shinozaki E, Suenaga M, Wakatsuki T, et al
    Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer.
    PLoS One. 2017;12:e0176745.
    PubMed     Text format     Abstract available
    
    
    
54. KNUDSEN KN, Lindebjerg J, Nielsen BS, Hansen TF, et al
    MicroRNA-200b is downregulated in colon cancer budding cells.
    PLoS One. 2017;12:e0178564.
    PubMed     Text format     Abstract available
    
    
    
55. HAN EC, Ryoo SB, Park JW, Yi JW, et al
    Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis: A propensity-matched study.
    PLoS One. 2017;12:e0178920.
    PubMed     Text format     Abstract available
    
    
    
56. GAO B, Yu T, Xue D, Sun B, et al
    A multidimensional integration analysis reveals potential bridging targets in the process of colorectal cancer liver metastasis.
    PLoS One. 2017;12:e0178760.
    PubMed     Text format     Abstract available
    
    
    
57. BURON A, Auge JM, Sala M, Roman M, et al
    Association between socioeconomic deprivation and colorectal cancer screening outcomes: Low uptake rates among the most and least deprived people.
    PLoS One. 2017;12:e0179864.
    PubMed     Text format     Abstract available
    
    
    
58. WANG J, Du S, Wang J, Fan W, et al
    The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.
    PLoS One. 2017;12:e0179670.
    PubMed     Text format     Abstract available
    
    
    
59. ZHANG Z, Chang Y, Zhang J, Lu Y, et al
    HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/beta-catenin pathway.
    PLoS One. 2017;12:e0179741.
    PubMed     Text format     Abstract available
    
    
    
60. KIM EK, Cho JH, Kim E, Kim YJ, et al
    Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth.
    PLoS One. 2017;12:e0181183.
    PubMed     Text format     Abstract available
    
    
    
61. LOPES-RAMOS CM, Barros BP, Koyama FC, Carpinetti PA, et al
    E2F1 somatic mutation within miRNA target site impairs gene regulation in colorectal cancer.
    PLoS One. 2017;12:e0181153.
    PubMed     Text format     Abstract available
    
    
    
62. RASMUSSEN SL, Krarup HB, Sunesen KG, Johansen MB, et al
    Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.
    PLoS One. 2017;12:e0180809.
    PubMed     Text format     Abstract available
    
    
    
63. POTOCNIK N, Perse M, Cerar A, Injac R, et al
    Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.
    PLoS One. 2017;12:e0181632.
    PubMed     Text format     Abstract available
    
    
    
64. URIBE DJ, Mandell EK, Watson A, Martinez JD, et al
    The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.
    PLoS One. 2017;12:e0179979.
    PubMed     Text format     Abstract available
    
    
    
65. LOCK FE, Babaian A, Zhang Y, Gagnier L, et al
    A novel isoform of IL-33 revealed by screening for transposable element promoted genes in human colorectal cancer.
    PLoS One. 2017;12:e0180659.
    PubMed     Text format     Abstract available
    
    
    January 2016
66. CHEN X, Deane NG, Lewis KB, Li J, et al
    Comparison of Nanostring nCounter(R) Data on FFPE Colon Cancer Samples and Affymetrix Microarray Data on Matched Frozen Tissues.
    PLoS One. 2016;11:e0153784.
    PubMed     Text format     Abstract available
    
    
    
67. HUO H, Zhou Z, Qin J, Liu W, et al
    Erastin Disrupts Mitochondrial Permeability Transition Pore (mPTP) and Induces Apoptotic Death of Colorectal Cancer Cells.
    PLoS One. 2016;11:e0154605.
    PubMed     Text format     Abstract available
    
    
    
68. VOGTMANN E, Hua X, Zeller G, Sunagawa S, et al
    Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing.
    PLoS One. 2016;11:e0155362.
    PubMed     Text format     Abstract available
    
    
    
69. CHOU CK, Chen SL, Yen AM, Chiu SY, et al
    Outreach and Inreach Organized Service Screening Programs for Colorectal Cancer.
    PLoS One. 2016;11:e0155276.
    PubMed     Text format     Abstract available
    
    
    
70. FOSTER C, Haviland J, Winter J, Grimmett C, et al
    Pre-Surgery Depression and Confidence to Manage Problems Predict Recovery Trajectories of Health and Wellbeing in the First Two Years following Colorectal Cancer: Results from the CREW Cohort Study.
    PLoS One. 2016;11:e0155434.
    PubMed     Text format     Abstract available
    
    
    
71. BUHL IK, Gerster S, Delorenzi M, Jensen T, et al
    Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data.
    PLoS One. 2016;11:e0155123.
    PubMed     Text format     Abstract available
    
    
    
72. LI B, Gan A, Chen X, Wang X, et al
    Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review.
    PLoS One. 2016;11:e0155095.
    PubMed     Text format     Abstract available
    
    
    
73. KIM JC, Ha YJ, Tak KH, Roh SA, et al
    Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer.
    PLoS One. 2016;11:e0155160.
    PubMed     Text format     Abstract available
    
    
    
74. AAN DE STEGGE WB, van Leeuwen BL, Elferink MA, de Bock GH, et al
    The Evaluation of More Lymph Nodes in Colon Cancer Is Associated with Improved Survival in Patients of All Ages.
    PLoS One. 2016;11:e0155608.
    PubMed     Text format     Abstract available
    
    
    
75. VAN HELDEN EJ, Hoekstra OS, Boellaard R, Roth C, et al
    Early 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.
    PLoS One. 2016;11:e0155178.
    PubMed     Text format     Abstract available
    
    
    
76. GORGES TM, Stein A, Quidde J, Hauch S, et al
    Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch(R) System and the AdnaTest(R).
    PLoS One. 2016;11:e0155126.
    PubMed     Text format     Abstract available
    
    
    
77. DI CARO G, Carvello M, Pesce S, Erreni M, et al
    Correction: Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer.
    PLoS One. 2016;11:e0156669.
    PubMed     Text format     Abstract available
    
    
    
78. HUSSAIN T, Chang HY, Luu NP, Pollack CE, et al
    The Value of Continuity between Primary Care and Surgical Care in Colon Cancer.
    PLoS One. 2016;11:e0155789.
    PubMed     Text format     Abstract available
    
    
    
79. ADAMS SV, Ceballos R, Newcomb PA
    Quality of Life and Mortality of Long-Term Colorectal Cancer Survivors in the Seattle Colorectal Cancer Family Registry.
    PLoS One. 2016;11:e0156534.
    PubMed     Text format     Abstract available
    
    
    
80. PALANIAPPAN A, Ramar K, Ramalingam S
    Computational Identification of Novel Stage-Specific Biomarkers in Colorectal Cancer Progression.
    PLoS One. 2016;11:e0156665.
    PubMed     Text format     Abstract available
    
    
    
81. EYKING A, Reis H, Frank M, Gerken G, et al
    MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer.
    PLoS One. 2016;11:e0156871.
    PubMed     Text format     Abstract available
    
    
    
82. HAMIDOU Z, Chibaudel B, Hebbar M, Hug de Larauze M, et al
    Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial.
    PLoS One. 2016;11:e0157067.
    PubMed     Text format     Abstract available
    
    
    
83. ALKHAYAL KA, Awadalia ZH, Vaali-Mohammed MA, Al Obeed OA, et al
    Association of Vitamin D Receptor Gene Polymorphisms with Colorectal Cancer in a Saudi Arabian Population.
    PLoS One. 2016;11:e0155236.
    PubMed     Text format     Abstract available
    
    
    
84. VELUCHAMY JP, Spanholtz J, Tordoir M, Thijssen VL, et al
    Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer.
    PLoS One. 2016;11:e0157830.
    PubMed     Text format     Abstract available
    
    
    
85. HU S, Zou Z, Li H, Zou G, et al
    The Preoperative Peripheral Blood Monocyte Count Is Associated with Liver Metastasis and Overall Survival in Colorectal Cancer Patients.
    PLoS One. 2016;11:e0157486.
    PubMed     Text format     Abstract available
    
    
    
86. LIN PC, Yang YF, Tyan YC, Hsiao ES, et al
    Identification of Phosphorylated Cyclin-Dependent Kinase 1 Associated with Colorectal Cancer Survival Using Label-Free Quantitative Analyses.
    PLoS One. 2016;11:e0158844.
    PubMed     Text format     Abstract available
    
    
    
87. NEGM OH, Hamed MR, Schoen RE, Whelan RL, et al
    Human Blood Autoantibodies in the Detection of Colorectal Cancer.
    PLoS One. 2016;11:e0156971.
    PubMed     Text format     Abstract available
    
    
    
88. GOGOI P, Sepehri S, Zhou Y, Gorin MA, et al
    Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples.
    PLoS One. 2016;11:e0147400.
    PubMed     Text format     Abstract available
    
    
    
89. NOVESKI P, Madjunkova S, Sukarova Stefanovska E, Matevska Geshkovska N, et al
    Loss of Y Chromosome in Peripheral Blood of Colorectal and Prostate Cancer Patients.
    PLoS One. 2016;11:e0146264.
    PubMed     Text format     Abstract available
    
    
    
90. SATO KA, Hachiya T, Iwaya T, Kume K, et al
    Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel.
    PLoS One. 2016;11:e0146275.
    PubMed     Text format     Abstract available
    
    
    
91. TIPTIRI-KOURPETI A, Spyridopoulou K, Santarmaki V, Aindelis G, et al
    Lactobacillus casei Exerts Anti-Proliferative Effects Accompanied by Apoptotic Cell Death and Up-Regulation of TRAIL in Colon Carcinoma Cells.
    PLoS One. 2016;11:e0147960.
    PubMed     Text format     Abstract available
    
    
    
92. FEIERSINGER F, Nolte E, Wach S, Rau TT, et al
    MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma.
    PLoS One. 2016;11:e0148580.
    PubMed     Text format     Abstract available
    
    
    
93. MAIDEN SL, Petrova YI, Gumbiner BM
    Microtubules Inhibit E-Cadherin Adhesive Activity by Maintaining Phosphorylated p120-Catenin in a Colon Carcinoma Cell Model.
    PLoS One. 2016;11:e0148574.
    PubMed     Text format     Abstract available
    
    
    
94. LEE LS, Seng KY, Wang LZ, Yong WP, et al
    Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI.
    PLoS One. 2016;11:e0147681.
    PubMed     Text format     Abstract available
    
    
    
95. CEA SORIANO L, Soriano-Gabarro M, Garcia Rodriguez LA
    The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice.
    PLoS One. 2016;11:e0159179.
    PubMed     Text format     Abstract available
    
    
    
96. TAKAYA A, Hirohashi Y, Murai A, Morita R, et al
    Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480.
    PLoS One. 2016;11:e0158903.
    PubMed     Text format     Abstract available
    
    
    
97. PHANG CW, Karsani SA, Sethi G, Abd Malek SN, et al
    Flavokawain C Inhibits Cell Cycle and Promotes Apoptosis, Associated with Endoplasmic Reticulum Stress and Regulation of MAPKs and Akt Signaling Pathways in HCT 116 Human Colon Carcinoma Cells.
    PLoS One. 2016;11:e0148775.
    PubMed     Text format     Abstract available
    
    
    
98. REYES-ZURITA FJ, Rufino-Palomares EE, Garcia-Salguero L, Peragon J, et al
    Maslinic Acid, a Natural Triterpene, Induces a Death Receptor-Mediated Apoptotic Mechanism in Caco-2 p53-Deficient Colon Adenocarcinoma Cells.
    PLoS One. 2016;11:e0146178.
    PubMed     Text format     Abstract available
    
    
    
99. JIMENEZ S, Gascon S, Luquin A, Laguna M, et al
    Rosa canina Extracts Have Antiproliferative and Antioxidant Effects on Caco-2 Human Colon Cancer.
    PLoS One. 2016;11:e0159136.
    PubMed     Text format     Abstract available
    
    
    
100. ZHOU J, Chang L, Guan Y, Yang L, et al
     Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer.
     PLoS One. 2016;11:e0159708.
     PubMed     Text format     Abstract available
     
     
     
101. KIM SH, Park YY, Cho SN, Margalit O, et al
     Kruppel-Like Factor 12 Promotes Colorectal Cancer Growth through Early Growth Response Protein 1.
     PLoS One. 2016;11:e0159899.
     PubMed     Text format     Abstract available
     
     
     
102. GRANDE R, Natoli C, Ciancola F, Gemma D, et al
     Treatment of Metastatic Colorectal Cancer Patients >/=75 Years Old in Clinical Practice: A Multicenter Analysis.
     PLoS One. 2016;11:e0157751.
     PubMed     Text format     Abstract available
     
     
     
103. COSTA-CABRAL S, Brough R, Konde A, Aarts M, et al
     CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
     PLoS One. 2016;11:e0149099.
     PubMed     Text format     Abstract available
     
     
     
104. KUAN CS, See Too WC, Few LL
     Sp1 and Sp3 Are the Transcription Activators of Human ek1 Promoter in TSA-Treated Human Colon Carcinoma Cells.
     PLoS One. 2016;11:e0147886.
     PubMed     Text format     Abstract available
     
     
     
105. SETH C, Ruiz I Altaba A
     Correction: Metastases and Colon Cancer Tumor Growth Display Divergent Responses to Modulation of Canonical WNT Signaling.
     PLoS One. 2016;11:e0160904.
     PubMed     Text format     Abstract available
     
     
     
106. CHEN W, Li Q, Fan Y, Li D, et al
     Factors Predicting Difficulty of Laparoscopic Low Anterior Resection for Rectal Cancer with Total Mesorectal Excision and Double Stapling Technique.
     PLoS One. 2016;11:e0151773.
     PubMed     Text format     Abstract available
     
     
     
107. NAM SK, Yun S, Koh J, Kwak Y, et al
     BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
     PLoS One. 2016;11:e0151865.
     PubMed     Text format     Abstract available
     
     
     
108. ERIKSEN AH, Andersen RF, Pallisgaard N, Sorensen FB, et al
     MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer.
     PLoS One. 2016;11:e0150593.
     PubMed     Text format     Abstract available
     
     
     
109. MARTINO-ECHARRI E, Brocardo MG, Mills KM, Henderson BR, et al
     Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of beta-Catenin Degradation-Competent Axin Puncta.
     PLoS One. 2016;11:e0150484.
     PubMed     Text format     Abstract available
     
     
     
110. PINTO AT, Pinto ML, Velho S, Pinto MT, et al
     Intricate Macrophage-Colorectal Cancer Cell Communication in Response to Radiation.
     PLoS One. 2016;11:e0160891.
     PubMed     Text format     Abstract available
     
     
     
111. CHANG YJ, Cheng YW, Lin RK, Huang CC, et al
     Thrombomodulin Influences the Survival of Patients with Non-Metastatic Colorectal Cancer through Epithelial-To-Mesenchymal Transition (EMT).
     PLoS One. 2016;11:e0160550.
     PubMed     Text format     Abstract available
     
     
     
112. KANG MR, Park KH, Yang JO, Lee CW, et al
     miR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells.
     PLoS One. 2016;11:e0160961.
     PubMed     Text format     Abstract available
     
     
     
113. JI K, Zhang M, Chu Q, Gan Y, et al
     The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis.
     PLoS One. 2016;11:e0160125.
     PubMed     Text format     Abstract available
     
     
     
114. NANDA N, Dhawan DK, Bhatia A, Mahmood A, et al
     Doxycycline Promotes Carcinogenesis & Metastasis via Chronic Inflammatory Pathway: An In Vivo Approach.
     PLoS One. 2016;11:e0151539.
     PubMed     Text format     Abstract available
     
     
     
115. CHEN JY, Tsai WS, Shao HJ, Wu JC, et al
     Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection.
     PLoS One. 2016;11:e0149633.
     PubMed     Text format     Abstract available
     
     
     
116. ZHANG J, Yi M, Zha L, Chen S, et al
     Sodium Butyrate Induces Endoplasmic Reticulum Stress and Autophagy in Colorectal Cells: Implications for Apoptosis.
     PLoS One. 2016;11:e0147218.
     PubMed     Text format     Abstract available
     
     
     
117. KIM H, Myoung S, Koom WS, Kim NK, et al
     MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection.
     PLoS One. 2016;11:e0146235.
     PubMed     Text format     Abstract available
     
     
     
118. YAN H, Hu K, Wu W, Li Y, et al
     Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
     PLoS One. 2016;11:e0159954.
     PubMed     Text format     Abstract available
     
     
     
119. SONG LP, Wang HY
     Modeling and Control of Colorectal Cancer.
     PLoS One. 2016;11:e0161349.
     PubMed     Text format     Abstract available
     
     
     
120. JO P, Konig A, Schirmer M, Kitz J, et al
     Heterogeneity of KRAS Mutation Status in Rectal Cancer.
     PLoS One. 2016;11:e0153278.
     PubMed     Text format     Abstract available
     
     
     
121. OKERBERG ES, Hainley A, Brown H, Aban A, et al
     Identification of a Tumor Specific, Active-Site Mutation in Casein Kinase 1alpha by Chemical Proteomics.
     PLoS One. 2016;11:e0152934.
     PubMed     Text format     Abstract available
     
     
     
122. BAJENOVA O, Gorbunova A, Evsyukov I, Rayko M, et al
     The Genome-Wide Analysis of Carcinoembryonic Antigen Signaling by Colorectal Cancer Cells Using RNA Sequencing.
     PLoS One. 2016;11:e0161256.
     PubMed     Text format     Abstract available
     
     
     
123. ILIC I, Jankovic S, Ilic M
     Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis.
     PLoS One. 2016;11:e0161912.
     PubMed     Text format     Abstract available
     
     
     
124. CHEN YG, Chen MQ, Guo YY, Li SC, et al
     Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
     PLoS One. 2016;11:e0153944.
     PubMed     Text format     Abstract available
     
     
     
125. SUNDSTROM A, Grabocka E, Bar-Sagi D, Mishra B, et al
     Histological Image Processing Features Induce a Quantitative Characterization of Chronic Tumor Hypoxia.
     PLoS One. 2016;11:e0153623.
     PubMed     Text format     Abstract available
     
     
     
126. ABULI A, Castells A, Bujanda L, Lozano JJ, et al
     Genetic Variants Associated with Colorectal Adenoma Susceptibility.
     PLoS One. 2016;11:e0153084.
     PubMed     Text format     Abstract available
     
     
     
127. ISSOP L, Ostuni MA, Lee S, Laforge M, et al
     Translocator Protein-Mediated Stabilization of Mitochondrial Architecture during Inflammation Stress in Colonic Cells.
     PLoS One. 2016;11:e0152919.
     PubMed     Text format     Abstract available
     
     
     
128. MILLER CL, Muthupalani S, Shen Z, Drees F, et al
     Lamellipodin-Deficient Mice: A Model of Rectal Carcinoma.
     PLoS One. 2016;11:e0152940.
     PubMed     Text format     Abstract available
     
     
     
129. HASEGAWA K, Saiura A, Takayama T, Miyagawa S, et al
     Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
     PLoS One. 2016;11:e0162400.
     PubMed     Text format     Abstract available
     
     
     
130. FALCONE E, Grandoni L, Garibaldi F, Manni I, et al
     Infinity: An In-Silico Tool for Genome-Wide Prediction of Specific DNA Matrices in miRNA Genomic Loci.
     PLoS One. 2016;11:e0153658.
     PubMed     Text format     Abstract available
     
     
     
131. CATALAN V, Gomez-Ambrosi J, Rodriguez A, Ramirez B, et al
     Increased Obesity-Associated Circulating Levels of the Extracellular Matrix Proteins Osteopontin, Chitinase-3 Like-1 and Tenascin C Are Associated with Colon Cancer.
     PLoS One. 2016;11:e0162189.
     PubMed     Text format     Abstract available
     
     
     
132. CHEN J, Raju GS, Jogunoori W, Menon V, et al
     Mutational Profiles Reveal an Aberrant TGF-beta-CEA Regulated Pathway in Colon Adenomas.
     PLoS One. 2016;11:e0153933.
     PubMed     Text format     Abstract available
     
     
     
133. GU X, Gao XS, Qin S, Li X, et al
     Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer.
     PLoS One. 2016;11:e0163523.
     PubMed     Text format     Abstract available
     
     
     
134. BOTTICELLI A, Borro M, Onesti CE, Strigari L, et al
     Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker?
     PLoS One. 2016;11:e0163105.
     PubMed     Text format     Abstract available
     
     
     
135. TSUKIHARA H, Tsunekuni K, Takechi T
     Folic Acid-Metabolizing Enzymes Regulate the Antitumor Effect of 5-Fluoro-2'-Deoxyuridine in Colorectal Cancer Cell Lines.
     PLoS One. 2016;11:e0163961.
     PubMed     Text format     Abstract available
     
     
     
136. NIRVANAPPA AC, Mohan CD, Rangappa S, Ananda H, et al
     Novel Synthetic Oxazines Target NF-kappaB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
     PLoS One. 2016;11:e0163209.
     PubMed     Text format     Abstract available
     
     
     
137. SOLASSOL J, Vendrell J, Markl B, Haas C, et al
     Multi-Center Evaluation of the Fully Automated PCR-Based Idylla KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.
     PLoS One. 2016;11:e0163444.
     PubMed     Text format     Abstract available
     
     
     
138. HUANG WS, Hsieh MC, Huang CY, Kuo YH, et al
     The Association of CXC Receptor 4 Mediated Signaling Pathway with Oxaliplatin-Resistant Human Colorectal Cancer Cells.
     PLoS One. 2016;11:e0159927.
     PubMed     Text format     Abstract available
     
     
     
139. CHANG YT, Huang MY, Yeh YS, Huang CW, et al
     A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer.
     PLoS One. 2016;11:e0163264.
     PubMed     Text format     Abstract available
     
     
     
140. BUDHATHOKI S, Yamaji T, Iwasaki M, Sawada N, et al
     Vitamin D Receptor Gene Polymorphism and the Risk of Colorectal Cancer: A Nested Case-Control Study.
     PLoS One. 2016;11:e0164648.
     PubMed     Text format     Abstract available
     
     
     
141. COMAS M, Mendivil J, Andreu M, Hernandez C, et al
     Long-Term Prediction of the Demand of Colonoscopies Generated by a Population-Based Colorectal Cancer Screening Program.
     PLoS One. 2016;11:e0164666.
     PubMed     Text format     Abstract available
     
     
     
142. SUN X, Hu Y, Zhang L, Hu C, et al
     Mining, Validation, and Clinical Significance of Colorectal Cancer (CRC)-Associated lncRNAs.
     PLoS One. 2016;11:e0164590.
     PubMed     Text format     Abstract available
     
     
     
143. LOPE V, Fernandez de Larrea N, Perez-Gomez B, Martin V, et al
     Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain.
     PLoS One. 2016;11:e0164620.
     PubMed     Text format     Abstract available
     
     
     
144. LIN J, Hiraoka K, Watanabe T, Kuo T, et al
     Identification of Binding Targets of a Pyrrole-Imidazole Polyamide KR12 in the LS180 Colorectal Cancer Genome.
     PLoS One. 2016;11:e0165581.
     PubMed     Text format     Abstract available
     
     
     
145. IGUCHI T, Nambara S, Masuda T, Komatsu H, et al
     miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver Metastasis.
     PLoS One. 2016;11:e0165912.
     PubMed     Text format     Abstract available
     
     
     
146. LENNARD KS, Goosen RW, Blackburn JM
     Bacterially-Associated Transcriptional Remodelling in a Distinct Genomic Subtype of Colorectal Cancer Provides a Plausible Molecular Basis for Disease Development.
     PLoS One. 2016;11:e0166282.
     PubMed     Text format     Abstract available
     
     
     
147. MIGUCHI M, Hinoi T, Shimomura M, Adachi T, et al
     Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor beta Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
     PLoS One. 2016;11:e0166422.
     PubMed     Text format     Abstract available
     
     
     
148. KAMIZA AB, Hsieh LL, Tang R, Chien HT, et al
     TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.
     PLoS One. 2016;11:e0167354.
     PubMed     Text format     Abstract available
     
     
     
149. YAP R, Wilkins S, Staples M, Oliva K, et al
     The Effect of Diabetes on the Perioperative Outcomes of Colorectal Cancer Surgery Patients.
     PLoS One. 2016;11:e0167271.
     PubMed     Text format     Abstract available
     
     
     
150. CHANDLER PD, Akinkuolie AO, Tobias DK, Lawler PR, et al
     Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality.
     PLoS One. 2016;11:e0165615.
     PubMed     Text format     Abstract available
     
     
     
151. ALAJEZ NM
     Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence.
     PLoS One. 2016;11:e0167455.
     PubMed     Text format     Abstract available
     
     
     
152. TOMINAGA T, Nonaka T, Sumida Y, Hidaka S, et al
     The C-Reactive Protein to Albumin Ratio as a Predictor of Severe Side Effects of Adjuvant Chemotherapy in Stage III Colorectal Cancer Patients.
     PLoS One. 2016;11:e0167967.
     PubMed     Text format     Abstract available
     
     
     
153. KAI M, Niinuma T, Kitajima H, Yamamoto E, et al
     TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells.
     PLoS One. 2016;11:e0168281.
     PubMed     Text format     Abstract available
     
     
     
154. RAMAKER K, Bade S, Rockendorf N, Meckelein B, et al
     Absence of the Epithelial Glycocalyx As Potential Tumor Marker for the Early Detection of Colorectal Cancer.
     PLoS One. 2016;11:e0168801.
     PubMed     Text format     Abstract available
     
     
     
155. ZHANG ZY, Li C, Gao W, Yin XW, et al
     A Nomogram to Predict Adequate Lymph Node Recovery before Resection of Colorectal Cancer.
     PLoS One. 2016;11:e0168156.
     PubMed     Text format     Abstract available
     
     
     
156. VARGAS T, Moreno-Rubio J, Herranz J, Cejas P, et al
     3'UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients.
     PLoS One. 2016;11:e0168423.
     PubMed     Text format     Abstract available
     
     
     
157. MULLINS CS, Huhns M, Krohn M, Peters S, et al
     Generation, Characterization and Application of Antibodies Directed against HERV-H Gag Protein in Colorectal Samples.
     PLoS One. 2016;11:e0153349.
     PubMed     Text format     Abstract available
     
     
     
158. WANG X, Ji P, Zhang Y, LaComb JF, et al
     Aberrant DNA Methylation: Implications in Racial Health Disparity.
     PLoS One. 2016;11:e0153125.
     PubMed     Text format     Abstract available
     
     
     
159. GALISSIER T, Schneider C, Nasri S, Kanagaratnam L, et al
     Biobanking of Fresh-Frozen Human Adenocarcinomatous and Normal Colon Tissues: Which Parameters Influence RNA Quality?
     PLoS One. 2016;11:e0154326.
     PubMed     Text format     Abstract available
     
     
     
160. BHARDWAJ M, Kim NH, Paul S, Jakhar R, et al
     5-Hydroxy-7-Methoxyflavone Triggers Mitochondrial-Associated Cell Death via Reactive Oxygen Species Signaling in Human Colon Carcinoma Cells.
     PLoS One. 2016;11:e0154525.
     PubMed     Text format     Abstract available
     
     
     
161. CARCHMAN EH, Matkowskyj KA, Meske L, Lambert PF, et al
     Dysregulation of Autophagy Contributes to Anal Carcinogenesis.
     PLoS One. 2016;11:e0164273.
     PubMed     Text format     Abstract available
     
     
     
162. PAN CH, Chang CC, Su CT, Tsai PS, et al
     Trends in Irritable Bowel Syndrome Incidence among Taiwanese Adults during 2003-2013: A Population-Based Study of Sex and Age Differences.
     PLoS One. 2016;11:e0166922.
     PubMed     Text format     Abstract available
     
     
     
163. KUNISAWA S, Fushimi K, Imanaka Y
     Reducing Length of Hospital Stay Does Not Increase Readmission Rates in Early-Stage Gastric, Colon, and Lung Cancer Surgical Cases in Japanese Acute Care Hospitals.
     PLoS One. 2016;11:e0166269.
     PubMed     Text format     Abstract available
     
     
     
164. MASOOMPOUR SM, Lankarani KB, Honarvar B, Tabatabaee SH, et al
     Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study.
     PLoS One. 2016;11:e0155669.
     PubMed     Text format     Abstract available
     
     
     January 2015
165. CHEN LX, Ning GZ, Zhou ZR, Li YL, et al
     The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies.
     PLoS One. 2015;10:e0123080.
     PubMed     Text format     Abstract available
     
     
     
166. MBANG PA, Kowalkowski MA, Amirian ES, Giordano TP, et al
     Association between Time on Protease Inhibitors and the Incidence of Squamous Cell Carcinoma of the Anus among U.S. Male Veterans.
     PLoS One. 2015;10:e0142966.
     PubMed     Text format     Abstract available
     
     
     
167. YING J, Lin C, Wu J, Guo L, et al
     Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population.
     PLoS One. 2015;10:e0144731.
     PubMed     Text format     Abstract available
     
     
     
168. CHATTOPADHYAY N, Berger AJ, Koenig E, Bannerman B, et al
     KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.
     PLoS One. 2015;10:e0144825.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: